SCHEMBL5277582

SCHEMBL5277582

CCC(O)c1ccccc1C(CCC(S)C1(CC(=O)O)CC1)c1cccc(C=Cc2ccc3ccc(Cl)cc3n2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYSLTR1 Q9Y271 5/20 0.51
▸ CYSLTR2 Q9NS75 3/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ ABCB11 O95342 2/20 0.50
▸ CYP2C8 P10632 2/20 0.50
▸ RECQL P46063 1/20 0.50
▸ BLM P54132 1/20 0.50
▸ EGFR P00533 1/20 0.50
▸ ESR1 P03372 1/20 0.50
▸ NR3C1 P04150 1/20 0.50
▸ FYN P06241 1/20 0.50
▸ PGR P06401 1/20 0.50
▸ ADRB2 P07550 1/20 0.50
▸ ADRB1 P08588 1/20 0.50
▸ ADRA2A P08913 1/20 0.50
▸ ADORA3 P0DMS8 1/20 0.50
▸ CHRM1 P11229 1/20 0.50
▸ ADRB3 P13945 1/20 0.50
▸ ADRA2B P18089 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3979199 0.84 CYSLTR1 (0.61) CYSLTR1CYSLTR2MEN1KMT2AABCB11
SCHEMBL5274558 0.84 CYSLTR1 (0.61) CYSLTR1CYSLTR2MEN1KMT2AABCB11
SCHEMBL625607 0.83 CYSLTR1 (0.52) CYSLTR1CYSLTR2MEN1KMT2AABCB11
SCHEMBL15921355 0.81 CYSLTR1 (0.54) CYSLTR1CYSLTR2MEN1KMT2AABCB11
SCHEMBL5275768 0.79 CYSLTR1 (0.48) CYSLTR1CYSLTR2MEN1KMT2AABCB11
SCHEMBL5271947 0.79 CYSLTR1 (0.48) CYSLTR1CYSLTR2MEN1KMT2AABCB11
SCHEMBL3041868 0.77 CYSLTR1 (0.79) CYSLTR1CYSLTR2MEN1KMT2AABCB11
SCHEMBL4742853 0.77 CYSLTR1 (0.79) CYSLTR1CYSLTR2MEN1KMT2AABCB11
SCHEMBL4248355 0.75 CYSLTR1 (0.57) CYSLTR1CYSLTR2MEN1KMT2AABCB11
SCHEMBL16332941 0.75 CYSLTR1 (0.62) CYSLTR1CYSLTR2MEN1KMT2AABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1853563-A1 SALT OF MONTELUKAST WITH TERT.-BUTYLAMINE INSTYTUT FARMACEUTYCZNY (PL) 2007-11-14 — — EP disclosed
WO-2006043846-A1 SALT OF MONTELUKAST WITH TERT.-BUTYLAMINE INSTYTUT FARMACEUTYCZNY (PL) 2006-04-27 — — WO disclosed
Send feedback